trial · primary record
JNJ-64042056
Alzheimer Disease
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 55 |
| Primary completion | 2027-01-05 |
| Primary endpoint | Change From Baseline in Brain Tau Burden as Measured by Tau PET in Specified Regions of Interest (ROI) |
| Registry ID | NCT06544616 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:03.291Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06544616
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.